Lasa Supergenerics Ltd.
NSE: LASA | BSE: 540702
₹7.99
₹-0.11
(-1.36%)
As on 22-May-2026IST
Market cap
₹40 Cr
Revenue (TTM)
₹64 Cr
P/E Ratio
--
P/B Ratio
0.7
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-44 Cr
-
ROE
-20.2 %
-
ROCE
-13.2 %
-
Industry P/E
38.63
-
EV/EBITDA
65.3
-
Debt to Equity
0.2
-
Book Value
₹10.7
-
EPS
₹-1.9
-
Face value
10
-
Shares outstanding
50,101,239
9 Years Aggregate
CFO
₹126.64 Cr
EBITDA
₹186.65 Cr
Net Profit
₹-36.60 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Lasa Supergenerics
| -15.4 | -8.5 | 1.7 | -50.3 | -30.4 | -36.6 | -- |
|
BSE Healthcare
| 8.8 | 8.8 | 9.7 | 11.0 | 27.5 | 14.1 | 12.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Lasa Supergenerics
| -64.7 | -10.7 | -11.1 | -50.9 | -18.8 | 354.8 | -43.4 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Lasa Supergenerics
|
8.0 | 39.9 | 64.4 | -44.2 | -16.2 | -13.6 | -- | 0.7 |
| 1,039.0 | 12,715.2 | 2,551.8 | 564.5 | 28.3 | 18.4 | 22.5 | 3.8 | |
| 441.1 | 7,642.0 | 1,053.1 | 293.6 | 32.3 | 24.6 | 26 | 5.9 | |
| 1,153.3 | 12,070.6 | 1,158.7 | 309.6 | 31.9 | 17.3 | 38.6 | 6.4 | |
| 1,713.6 | 32,463.4 | 9,203.5 | 941.3 | 15.4 | 19.6 | 35.1 | 6.6 | |
| 368.7 | 4,019.2 | 159.3 | 47.8 | 39.0 | 18.6 | 84.1 | 14.5 | |
| 16,693.0 | 21,341.3 | 2,023.0 | 364.0 | 23.9 | 20.8 | 58.6 | 11.4 | |
| 1,111.0 | 5,114.0 | 649.5 | 121.6 | 23.7 | 13.2 | 44.3 | 5.5 | |
| 673.4 | 7,586.2 | 502.0 | 138.7 | -- | 32.8 | 43.9 | 8.6 | |
| 265.5 | 7,015.0 | 7.1 | -276.3 | -4,077.5 | -63.3 | -- | 11.9 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Lasa Supergenerics
Lasa Supergenerics Limited engages in the research, manufacture, and marketing of animal and human healthcare products in India. It offers API bulk drug products comprising fenbendazole, toldimphos sodium, cyromazine, albendazole, ricobendazole,... triciabendazole, oxfendazole, closantel base, closantel sodium dihydrate BP, nitroxynil, rafoxanide, oxyclozanide, ornidazole, halquinol, and 2,6-diiodo-4-nitrophenol; and other API products. The company also provides animal feed ingredients, including calcium iodate; and reagents for therapeutic use, such as potassium iodide. In addition, it exports its products. Lasa Supergenerics Limited was incorporated in 2016 and is based in Ratnagiri, India. Read more
-
Incorporated
2016
-
Chairman
Omkar Pravin Herlekar
-
Managing Director
Omkar Pravin Herlekar
-
Headquarters
Ratnagiri Dist, Maharashtra
-
Website
Looking for more details about Lasa Supergenerics Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsResults For Quarter Ended 31St December 2025
13-Feb-2026No News & Announcements are available.
FAQs for Lasa Supergenerics
What is the current share price of Lasa Supergenerics Ltd Today?
The share price of Lasa Supergenerics Ltd is ₹7.99 (NSE) and ₹7.96 (BSE) as of 22-May-2026 IST. Lasa Supergenerics Ltd has given a return of -30.35% in the last 3 years.
What is the current PB & PE ratio of Lasa Supergenerics Ltd?
Since, TTM earnings of Lasa Supergenerics Ltd is negative, P/E ratio is not available.
The P/B ratio of Lasa Supergenerics Ltd is 0.74 times as on 22-May-2026, a 68 discount to its peers’ median range of 2.30 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2024
|
0.00
|
1.14
|
|
2023
|
0.00
|
0.78
|
|
2022
|
0.00
|
1.32
|
|
2021
|
10.70
|
1.53
|
|
2020
|
31.84
|
0.82
|
What is the 52 Week High and Low of Lasa Supergenerics Ltd?
The 52-week high and low of Lasa Supergenerics Ltd are Rs 19.00 and Rs 5.67 as of 23-May-2026.
What is the market cap of Lasa Supergenerics Ltd?
Lasa Supergenerics Ltd has a market capitalisation of ₹ 40 Cr as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Lasa Supergenerics Ltd?
Before investing in Lasa Supergenerics Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.